Dr John R Spurzem, MD | |
3260 Kerner Blvd, San Rafael, CA 94901-4840 | |
(415) 448-1500 | |
Not Available |
Full Name | Dr John R Spurzem |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 3260 Kerner Blvd, San Rafael, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467489930 | NPI | - | NPPES |
09829571 | Medicaid | MS | |
P01081272 | Other | MS | RAILROAD MEDICARE |
1048895 | Medicaid | LA | |
192669 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | G89192 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John R Spurzem, MD 523 San Pedro Cv, San Rafael, CA 94901-2478 Ph: (601) 209-8064 | Dr John R Spurzem, MD 3260 Kerner Blvd, San Rafael, CA 94901-4840 Ph: (415) 448-1500 |
News Archive
Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
Like any law-abiding train passenger, a molecule called oskar RNA carries a stamped ticket detailing its destination and form of transport, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have found.
Treatments for high blood pressure do not totally reverse its damaging effects on the vascular rhythms that help circulation of the blood say researchers.
› Verified 8 days ago
Peter Reidy, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 99 Montecillo Rd, San Rafael, CA 94903 Phone: 415-444-4885 | |
Maurice D. Kinsolving, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 99 Montecillo Rd, San Rafael, CA 94903 Phone: 415-444-2000 | |
Dr. David J. Sulciner, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 99 Montecillo Rd, San Rafael, CA 94903 Phone: 415-444-2000 | |
Dr. Henry N Hulter, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 17 Wellbrock Hts, San Rafael, CA 94903 Phone: 415-978-1458 | |
Dr. Nels Marcus Thygeson, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 24 Mooring Rd, San Rafael, CA 94901 Phone: 651-269-1404 | |
Jeffrey S. Harris, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 99 Montecillo Rd, San Rafael, CA 94903 Phone: 415-444-2000 | |
Dr. David N Chernoff, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 550 Bret Harte Rd, San Rafael, CA 94901 Phone: 415-459-6601 Fax: 415-459-6602 |